Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nature Beta Technologies (NBT) is a biotechnology company specializing in the commercial cultivation of microalgae, specifically Dunaliella salina. Located in Eilat, Israel, the company leverages the region's high solar radiation and hypersaline conditions to produce high concentrations of natural beta-carotene. NBT's products are utilized globally in the nutraceutical, food, and cosmetic industries as natural colorants and antioxidant supplements. The company operates as a subsidiary of the Japanese Nikken Sohonsha Corporation and is recognized for its pioneering research in algal biotechnology. Its manufacturing facilities adhere to strict quality standards to ensure the purity of its algal biomass and extracts. NBT was one of the first companies to successfully scale microalgae production for the global health market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nature Beta Technologies.